WESTBURY, N.Y., April 19 / PRNewswire / — Tishcon Corp. announced that the U.S. FDA has granted the firm Orphan Drug Designations for UBIQUINOL (Coenzyme Q10) in the treatment of Pediatric Congestive Heart Failure and Huntington’s Disease.
Specialty Products
Tishcon Corp. offers a range of specialty products for the natural products, nutritional supplements, nutraceuticals, and vitamin industries, which are available to market under your product name or ours.
Memberships
GOED
The Global Organization for EPA & DHA Omega-3s
NSF
Supplement and Vitamin Certification
ICQA
International Coenzyme Q10 Association
CoQ10
CoQ10 Association
ABC
American Botanical Council
NPA
Natural Products Association
AHPA
American Herbal Products Association
CRN
Council for Responsible Nutrition